Journal Newsview all

Friday, April 24, 2015 | Source: Circulation: Cardiovascular Interventions

Activated Clotting Time May Predict Ischemic Events in PCI Patients on Heparin Alone

By L.A. McKeown

In patients with NSTE-ACS on heparin monotherapy during PCI, lower activated clotting time (ACT) values do not predict bleeding events but do correlate…

Friday, April 24, 2015 | Source: JACC: Cardiovascular Interventions

Registry Finds No Stark Differences Between Proximal, Distal Embolic Protection in CAS

By Caitlin E. Cox

Fewer than 1 in 15 US patients undergoing elective CAS are treated using proximal rather than distal embolic protection, according to a registry…

Thursday, April 23, 2015 | Source: American Journal of Cardiology

Length of Time Between Staged PCI, TAVR Minimally Affects Short-term Outcomes

By Yael L. Maxwell

Timing of staged PCI before TAVR does not affect long-term clinical outcomes or survival, according to a study published online March 24, 2015,…

Thursday, April 23, 2015 | Source: JAMA Internal Medicine

Substantial Minority of Low-Risk A-fib Patients Still Given Anticoagulants

By Salynn Boyles

As many as 1 in 4 A-fib patients at low thromboembolic risk are prescribed oral anticoagulants, according a research letter online April 13, 2015,…

Wednesday, April 22, 2015

Dual Antiplatelet Therapy Tied to Better Outcomes in High Risk PAD Patients

By Leah Lawrence

In patients with advanced PAD, dual antiplatelet therapy (DAPT) may confer additional long-term cardiovascular and survival benefits, according to…

Wednesday, April 22, 2015 | Source: Journal of the American College of Cardiology

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

By Kim Dalton

For patients on an oral anticoagulant and aspirin, the addition of clopidogrel for 6 weeks after stent implantation offers no net clinical benefit…

Tuesday, April 21, 2015 | Source: JACC: Cardiovascular Interventions

Radial RIVALs Femoral Access, Especially in Women

By Yael L. Maxwell
Because women undergoing cardiac cath are at higher risk of vascular access site complications than men, they may benefit more from radial procedures,…
Monday, April 20, 2015 | Source: Journal of the American College of Cardiology

High-Sensitivity Troponin Assay More Precisely Calibrates Mortality Risk in Suspected ACS Patients

By Kim Dalton
Use of a new high-sensitivity (hs) cardiac troponin T assay in patients with suspected ACS detects minor troponin elevations in many that may not have…
Friday, April 17, 2015 | Source: US Food and Drug Administration

FDA Panel Backs Cangrelor for Use in PCI

By Todd Neale

Cangrelor, a novel P2Y12 inhibitor given intravenously, has been endorsed by an FDA advisory committee for use in PCI—specifically for patients…

Friday, April 17, 2015 | Source: Stroke

IMS III: Adding Endovascular Therapy to IV tPA Boosts Function, QoL After Severe Stroke

By L.A. McKeown

Endovascular therapy boosts quality of life (QoL) and functional outcomes in patients with severe stroke over IV tissue plasminogen activator (tPA)…

Conference Newsview all

Friday, March 20, 2015 | Source: ACC.15 and TCT@ACC-i2

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

By Todd Neale

SAN DIEGO, CA—Late-breaking clinical research presented March 14-16, 2015, at the American College of Cardiology/i2 Scientific Session spanned multiple…

Tuesday, March 17, 2015 | Source: ACC.15 and TCT@ACC-i2

Small Study Suggests Benefits of Denervation for Pulmonary Arterial Hypertension

By Todd Neale

SAN DIEGO, CA—Catheter-based denervation of the pulmonary artery is associated with improvements in functional outcomes and hemodynamic variables…

Tuesday, March 17, 2015 | Source: ACC.15 and TCT@ACC-i2

TVT Registry: MitraClip Holds Up Well in Early US Commercial Experience

By L.A. McKeown

SAN DIEGO, CA—Initial US use of transcatheter mitral valve repair (TMVR) has resulted in high procedural success and low complication rates, according…

Tuesday, March 17, 2015 | Source: ACC.15 and TCT@ACC-i2

MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin

By Todd Neale

SAN DIEGO, CA—Among ACS patients undergoing invasive management, the use of radial vs femoral access improves outcomes, driven by reductions in major…

Tuesday, March 17, 2015 | Source: ACC.15 and TCT@ACC-i2

DANAMI3-PRIMULTI: Complete Revascularization Improves Outcomes for STEMI

By Yael L. Maxwell

SAN DIEGO, CA—Complete revascularization using FFR-guided PCI in STEMI patients reduces adverse events at 1 year compared with infarct-related artery…

Monday, March 16, 2015 | Source: ACC.15 and TCT@ACC-i2

ERRICA: Remote Ischemic Preconditioning Fails to Improve Long-Term Outcomes After CABG

By Yael L. Maxwell

SAN DIEGO, CA—Remote ischemic conditioning prior to on-pump CABG in high-risk patients fails to reduce long-term adverse events, according to results…

Monday, March 16, 2015 | Source: ACC.15 and TCT@ACC-i2

TOTAL: Use of Routine Thrombectomy in Primary PCI Takes Another Blow

By Todd Neale

SAN DIEGO, CA—Performing manual thrombectomy routinely prior to primary PCI does not improve 180-day outcomes among patients with STEMI over PCI alone,…

Monday, March 16, 2015 | Source: ACC.15 and TCT@ACC-i2

Early Invasive Strategy Dramatically Lowers Risk of Death, MI in Older NSTE-ACS Patients

By L.A. McKeown

SAN DIEGO, CA—Patients over age 80 who have NSTE-ACS or unstable angina are less likely to die, suffer an MI, or need urgent revascularization with…

Monday, March 16, 2015 | Source: ACC.15 and TCT@ACC-i2

DEFLECT III: TAVR Neuroprotection Device Safely Reduces Lesion Volume

By Yael L. Maxwell

SAN DIEGO, CA—Use of a novel neuroprotection during TAVR is safe and has the potential to eradicate cerebral lesions that cause stroke, according…

Monday, March 16, 2015 | Source: ACC.15 and TCT@ACC-i2

BEST: Due to Less TVR, CABG Still Favored Over PCI in Patients with Multivessel Disease

By L.A. McKeown

SAN DIEGO, CA—Even with the availability of newer-generation DES, patients with multivessel coronary artery disease still have better outcomes with…